Skip to main content
Erschienen in: Digestive Diseases and Sciences 5/2022

27.07.2021 | Original Article

Periodic Colonoscopies Are Associated with Improved Survival and Prognosis of Colorectal Cancer in Ulcerative Colitis

verfasst von: Neeraj Narula, Anne Hu, Geoffrey C. Nguyen, Jagadish Rangrej, John K. Marshall

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Background and Study Aims

This study aimed to identify whether ulcerative colitis (UC) patients who develop colorectal cancer (CRC) present at earlier stages of CRC and have improved survival if prior to their CRC diagnosis, they underwent intermittent follow-up colonoscopies compared to those who have no follow-up colonoscopies.

Methods

Patients with UC who developed primary CRC were identified using data provided by the Institute for Clinical Evaluative Sciences. We defined low-risk CRC stage as estimated 5-year survival ≥ 80% compared to high-risk CRC as 5-year survival < 80%.

Results

A total of 421 patients were identified with UC and CRC. The 15-year mortality rate was significantly higher in those who did not have follow-up colonoscopy (33/74; 44.6%) compared to the follow-up group (105/347; 30.3%) (p = 0.0172). Among the 219 patients with UC with staging information available, patients who did not have follow-up colonoscopy were more likely to present with high-risk CRC (24/31; 77.4%) compared with patients who had follow-up colonoscopies (88/188; 44.4%) (p = 0.0016). Those who underwent follow-up colonoscopies at average intervals ≤ 3 years presented with high-risk CRC 41.3% of the time, which was less than the 48.6% in those with less frequent colonoscopies and 77.4% in those with no follow-up (p = 0.0048).

Conclusions

Patients with UC who underwent intermittent follow-up colonoscopies had CRC detected at earlier stages and improvement in all-cause mortality, compared to those who with no follow-up colonoscopies. This may support regular surveillance colonoscopies for patients with UC.
Literatur
1.
Zurück zum Zitat Ekbom A, Helmick CG, Zack M, Holmberg L, Adami HO. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology. 1992;103:954–960.CrossRef Ekbom A, Helmick CG, Zack M, Holmberg L, Adami HO. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology. 1992;103:954–960.CrossRef
2.
Zurück zum Zitat Jussila A, Virta LJ, Pukkala E, Farkkila MA. Mortality and causes of death in patients with inflammatory bowel disease: a nationwide register study in Finland. J Crohns Colitis. 2014;8:1088–1096.CrossRef Jussila A, Virta LJ, Pukkala E, Farkkila MA. Mortality and causes of death in patients with inflammatory bowel disease: a nationwide register study in Finland. J Crohns Colitis. 2014;8:1088–1096.CrossRef
3.
Zurück zum Zitat Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–535.CrossRef Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–535.CrossRef
4.
Zurück zum Zitat Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10:639–645.CrossRef Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10:639–645.CrossRef
5.
Zurück zum Zitat Herrinton LJ, Liu L, Levin TR, Allison JE, Lewis JD, Velayos F. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012;143:382–389.CrossRef Herrinton LJ, Liu L, Levin TR, Allison JE, Lewis JD, Velayos F. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012;143:382–389.CrossRef
6.
Zurück zum Zitat Jess T, Simonsen J, Jorgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012;143:375–81.e1; quiz e13–4. Jess T, Simonsen J, Jorgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012;143:375–81.e1; quiz e13–4.
7.
Zurück zum Zitat Beaugerie L, Svrcek M, Seksik P, Bouvier AM, Simon T, Allez M et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology. 2013;145:166–75.e8.CrossRef Beaugerie L, Svrcek M, Seksik P, Bouvier AM, Simon T, Allez M et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology. 2013;145:166–75.e8.CrossRef
8.
Zurück zum Zitat Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11:649–70. Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11:649–70.
9.
Zurück zum Zitat Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571–607.CrossRef Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571–607.CrossRef
10.
Zurück zum Zitat Centre for Clinical Practice at N. National Institute for Health and Clinical Excellence: Guidance. Colonoscopic Surveillance for Prevention of Colorectal Cancer in People with Ulcerative Colitis, Crohn's Disease or Adenomas. London: National Institute for Health and Clinical Excellence (UK). National Institute for Health and Clinical Excellence.; 2011. Centre for Clinical Practice at N. National Institute for Health and Clinical Excellence: Guidance. Colonoscopic Surveillance for Prevention of Colorectal Cancer in People with Ulcerative Colitis, Crohn's Disease or Adenomas. London: National Institute for Health and Clinical Excellence (UK). National Institute for Health and Clinical Excellence.; 2011.
11.
Zurück zum Zitat Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:738–745.CrossRef Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:738–745.CrossRef
12.
Zurück zum Zitat Shergill AK, Lightdale JR, Bruining DH, Acosta RD, Chandrasekhara V, Chathadi KV, et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc. 2015;81:1101-21.e1-13. Shergill AK, Lightdale JR, Bruining DH, Acosta RD, Chandrasekhara V, Chathadi KV, et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc. 2015;81:1101-21.e1-13.
13.
Zurück zum Zitat Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114:384–413.CrossRef Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114:384–413.CrossRef
14.
Zurück zum Zitat Leddin D, Hunt R, Champion M, Cockeram A, Flook N, Gould M et al. Canadian association of gastroenterology and the canadian digestive health foundation: guidelines on colon cancer screening. Can J Gastroenterol. 2004;18:93–99.CrossRef Leddin D, Hunt R, Champion M, Cockeram A, Flook N, Gould M et al. Canadian association of gastroenterology and the canadian digestive health foundation: guidelines on colon cancer screening. Can J Gastroenterol. 2004;18:93–99.CrossRef
15.
Zurück zum Zitat Benchimol EI, Guttmann A, Griffiths AM, Rabeneck L, Mack DR, Brill H, et al. M1146 The Ontario Crohn's & Colitis cohort: validation of an algorithm to identify children diagnosed with inflammatory bowel disease using health administrative data. Gastroenterology. 2009;136:A-359-A-60. Benchimol EI, Guttmann A, Griffiths AM, Rabeneck L, Mack DR, Brill H, et al. M1146 The Ontario Crohn's & Colitis cohort: validation of an algorithm to identify children diagnosed with inflammatory bowel disease using health administrative data. Gastroenterology. 2009;136:A-359-A-60.
16.
Zurück zum Zitat Benchimol EI, Guttmann A, Griffiths AM, Rabeneck L, Mack DR, Brill H et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut. 2009;58:1490–1497.CrossRef Benchimol EI, Guttmann A, Griffiths AM, Rabeneck L, Mack DR, Brill H et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut. 2009;58:1490–1497.CrossRef
17.
Zurück zum Zitat Benchimol EI, Mack DR, Nguyen GC, Snapper SB, Li W, Mojaverian N, et al. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease. Gastroenterology. 2014;147:803–13.e7; quiz e14–5. Benchimol EI, Mack DR, Nguyen GC, Snapper SB, Li W, Mojaverian N, et al. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease. Gastroenterology. 2014;147:803–13.e7; quiz e14–5.
18.
Zurück zum Zitat Crooke H, Kobayashi M, Mitchell B, Nwokeji E, Laurie M, Kamble S, et al. Estimating 1-and 5-year relative survival trends in colorectal cancer (CRC) in the United States: 2004 to 2014. Journal of Clinical Oncology. 2018;36:587. Crooke H, Kobayashi M, Mitchell B, Nwokeji E, Laurie M, Kamble S, et al. Estimating 1-and 5-year relative survival trends in colorectal cancer (CRC) in the United States: 2004 to 2014. Journal of Clinical Oncology. 2018;36:587.
19.
Zurück zum Zitat JM B, Altman D. Survival probabilities. The Kaplan-Meier Method. BMJ. 1998:1572. JM B, Altman D. Survival probabilities. The Kaplan-Meier Method. BMJ. 1998:1572.
20.
Zurück zum Zitat Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2009;7:770–5; quiz 11. Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2009;7:770–5; quiz 11.
21.
Zurück zum Zitat Pan J, Xin L, Ma YF, Hu LH, Li ZS. Colonoscopy reduces colorectal cancer incidence and mortality in patients with non-malignant findings: a meta-analysis. Am J Gastroenterol. 2016;111:355–365.CrossRef Pan J, Xin L, Ma YF, Hu LH, Li ZS. Colonoscopy reduces colorectal cancer incidence and mortality in patients with non-malignant findings: a meta-analysis. Am J Gastroenterol. 2016;111:355–365.CrossRef
22.
Zurück zum Zitat Stock D, Paszat LF, Rabeneck L. Colorectal cancer mortality reduction is associated with having at least 1 colonoscopy within the previous 10 years among a population-wide cohort of screening age. Gastrointest Endosc. 2016;84:133–141.CrossRef Stock D, Paszat LF, Rabeneck L. Colorectal cancer mortality reduction is associated with having at least 1 colonoscopy within the previous 10 years among a population-wide cohort of screening age. Gastrointest Endosc. 2016;84:133–141.CrossRef
23.
Zurück zum Zitat Atkin W, Wooldrage K, Brenner A, Martin J, Shah U, Perera S et al. Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study. Lancet Oncol. 2017;18:823–834.CrossRef Atkin W, Wooldrage K, Brenner A, Martin J, Shah U, Perera S et al. Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study. Lancet Oncol. 2017;18:823–834.CrossRef
24.
Zurück zum Zitat Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S et al. Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2015;13:322–9.e1.CrossRef Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S et al. Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2015;13:322–9.e1.CrossRef
25.
Zurück zum Zitat Choi PM, Nugent FW, Schoetz DJ Jr, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993;105:418–424.CrossRef Choi PM, Nugent FW, Schoetz DJ Jr, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993;105:418–424.CrossRef
26.
Zurück zum Zitat Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut. 1998;42:711–714.CrossRef Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut. 1998;42:711–714.CrossRef
27.
Zurück zum Zitat Bye WA, Nguyen TM, Parker CE, Jairath V, East JE. Strategies for detecting colon cancer in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2017;9:Cd000279. Bye WA, Nguyen TM, Parker CE, Jairath V, East JE. Strategies for detecting colon cancer in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2017;9:Cd000279.
28.
Zurück zum Zitat Choi CH, Rutter MD, Askari A, Lee GH, Warusavitarne J, Moorghen M et al. Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: an updated overview. Am J Gastroenterol. 2015;110:1022–1034.CrossRef Choi CH, Rutter MD, Askari A, Lee GH, Warusavitarne J, Moorghen M et al. Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: an updated overview. Am J Gastroenterol. 2015;110:1022–1034.CrossRef
29.
Zurück zum Zitat Lashner BA, Kane SV, Hanauer SB. Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol. 1990;85:1083–1087.PubMed Lashner BA, Kane SV, Hanauer SB. Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol. 1990;85:1083–1087.PubMed
Metadaten
Titel
Periodic Colonoscopies Are Associated with Improved Survival and Prognosis of Colorectal Cancer in Ulcerative Colitis
verfasst von
Neeraj Narula
Anne Hu
Geoffrey C. Nguyen
Jagadish Rangrej
John K. Marshall
Publikationsdatum
27.07.2021
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 5/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07151-7

Weitere Artikel der Ausgabe 5/2022

Digestive Diseases and Sciences 5/2022 Zur Ausgabe

DDS-SIRC Author Profile

Author Spotlight: Marzia Varanese

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.